JOEY AZOFEIFA, PhD
CEO, Arpeggio Biosciences
Joey Azofeifa completed a PhD in Computer Science focused at the intersection of precision medicine and AI. After training at Merck and FORMA therapeutics, Joey started Arpeggio Bio to directly build a pipeline of medicine focused on drugging transcription factors. Since starting Arpeggio, Joey has raised over $20M in venture capital funding and has partnered Arpeggio's technology with leading pharmaceutical companies like J&J.